Compare · OFIX vs SYK
OFIX vs SYK
Side-by-side comparison of Orthofix Medical Inc. (OFIX) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OFIX and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $121.36B, about 414.7x OFIX ($292.7M).
- SYK has been more active in the news (12 items in the past 4 weeks vs 5 for OFIX).
- SYK has more recent analyst coverage (25 ratings vs 10 for OFIX).
- Company
- Orthofix Medical Inc.
- Stryker Corporation
- Price
- -
- -
- Market cap
- $292.7M
- $121.36B
- 1M return
- -
- +12.73%
- 1Y return
- -
- -13.30%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 1992
- News (4w)
- 5
- 12
- Recent ratings
- 10
- 25
Orthofix Medical Inc.
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest OFIX
- SEC Form 10-Q filed by Orthofix Medical Inc.
- Orthofix Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
- President, Global Limb Recon Fisher Patrick sold $1,360 worth of shares (150 units at $9.07) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 50,769 units (SEC Form 4)
- Orthofix to Report Third Quarter 2026 Financial Results
- President, Global Limb Recon Fisher Patrick sold $1,416 worth of shares (150 units at $9.44) as part of a pre-agreed trading plan (SEC Form 4)
- Amendment: Large owner Juniper Investment Company, Llc bought $2,732,097 worth of shares (310,000 units at $8.81) (SEC Form 4)
- SEC Form 4 filed by Large owner Juniper Investment Company, Llc
- President, Global Limb Recon Fisher Patrick sold $1,408 worth of shares (150 units at $9.39) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 51,069 units (SEC Form 4)
- President, Global Limb Recon Fisher Patrick sold $13,067 worth of shares (1,295 units at $10.09), decreasing direct ownership by 2% to 51,219 units (SEC Form 4) (for withholding tax)
Latest SYK
- Director Stryker Ronda E sold $178,924,731 worth of shares (550,000 units at $325.32) (SEC Form 4)
- Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Stryker announces intention to nominate Jim Davis to board of directors
- What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street
- SEC Form S-3ASR filed by Stryker Corporation
- SEC Form IRANNOTICE filed by Stryker Corporation
- SEC Form 10-Q filed by Stryker Corporation
- Stryker downgraded by Canaccord Genuity with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker reports third quarter 2026 operating results